The Valley Desk

ArticleThe oncologistPublished

Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
The oncologist
Published
Subject terms
Humans; Neoplasm Metastasis; Recombinant Fusion Proteins; Retrospective Studies; Adult; Aged; Middle Aged; Female; Male; Uveal Melanoma; ctDNA; Tebentafusp
PubMed ID
41021466
PubMed Central ID
PMC12574324
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal